AzTrials
AzTrials

Partner Notification Following STI DiagnosisNCT01720641

Partner Notification Strategies for MSM in Peru

A study testing Internet, Referral Card and Internet and Referral Card in people with Partner Notification Following STI Diagnosis, run by University of California, Los Angeles at 1 site in Peru.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of the proposed research is to assess new strategies for partner management and sexually transmitted infection (STI) control to reduce the spread of HIV-1 among men who have sex with men (MSM) in Latin America. The HIV epidemic in Peru remains concentrated within the core risk group of MSM. Read more about this study

Who is it for?
Ages 18 years and older, men only
What is being tested?
Internet, Referral Card and Internet and Referral Card
Could I receive a placebo?
No, everyone receives an active treatment
How many people
370 participants
Where
1 sitePeru
Study dates
Aug 2012to Aug 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years of age or older
  • Male or biologically male at birth
  • Sexual contact (oral or anal intercourse) with a male or male-to-female transgender partner in the past 12 months
  • Diagnosis with syphilis infection

Who cannot join

  • Under 18 years of age
  • Unable to understand informed consent procedures

Trial locations and contacts

1 site in 1 country.

Peru1 site
  • Asociacion Civil Impacta Salud y Educacion

    Lima

Other trials in Peru

About this study

Official title: Partner Notification Strategies for STI Control in Urban Peru

The goal of the proposed research is to assess new strategies for partner management and sexually transmitted infection (STI) control to reduce the spread of HIV-1 among men who have sex with men (MSM) in Latin America. The HIV epidemic in Peru remains concentrated within the core risk group of MSM. STI infection and re-infection are central to the continuation of the HIV epidemic among MSM in Peru. Development of improved strategies for partner notification and treatment will reduce the incidence and prevalence of STIs and ultimately reduce the incidence of HIV infection in this population. The first phase of this study used qualitative methods to explore attitudes and practices related to partner notification among MSM in Lima, Peru. Findings from the qualitative research were used to develop a quantitative survey instrument to assess partner notification decision-making processes and practices among MSM in Peru recently diagnosed with HIV or syphilis infection. Data from both quantitative and qualitative phases of the study have been used to develop a partner notification for MSM in Peru. Investigators plan to implement and assess the impact of the intervention on rates of partner notification following a diagnosis of syphilis among MSM in Lima, Peru. The investigators hypothesize that participants randomized to receive one or more partner notification tools will report a higher frequency of partner notification.

Read the detailed description

Specific Aim: To assess the efficacy of internet- and referral card-based partner notification tools for the improvement of partner notification outcomes among MSM in Lima, Peru. As attitudes and behaviors related to partner notification vary within specific behavioral, social, and clinical contexts, interventions designed to improve partner notification outcomes must address the same contextual determinants to be effective. Partner notification tools based on electronic distribution of anonymous notification messages and/or patient-delivered referral cards are expected to increase notification rates in specific contexts.

Hypothesis: Provision of partner notification tools based on electronic and printed resources will improve reported and observed partner notification outcomes by overcoming barriers to notification including limited contact information, fear of disclosure, stigma, and lack of informational resources. Notification outcomes and use of notification tools will vary according to strategies of interpersonal communication reflected in the specific behavioral, social, and biomedical contexts of the individual, the partnership, and the STI diagnosed.

Participants will be selected for participation in the study depending on the findings of the EPT/Partner Notification Screening Protocol. Participants in the EPT/Partner Notification Screening Protocol diagnosed with new syphilis infection will be eligible for enrollment in the Partner Notification protocol.

  1. Recruitment: Participants in the EPT/Partner Notification Screening Protocol who are diagnosed with syphilis based on physician interpretation of results of RPR assay and clinical history will be invited by the Study Counselor to participate in the Partner Notification Intervention Protocol.

II. Informed Consent: All potential subjects will receive an explanation of the study procedures and risks and benefits and asked to provide written Informed Consent. Participants will be given the opportunity to take the Informed Consent Document home for further review and decide at a later time if they wish to participate in the study.

III. Enrollment: Subjects who consent to participate in the Partner Notification Intervention Protocol will be randomized to either the experimental Partner Notification intervention or the Standard of Care (Partner Notification Counseling) arm.

IV Randomization: Eligible subjects who provide consent to participate will be randomly assigned to intervention or control groups using a random permuted block allocation (block size=7 in an alternating 4/3 ratio). Computer-generated randomization assignments will be stored in opaque, sealed envelopes opened at the time of allocation. Randomization assignments will be recorded and identified by the participant's numeric study code.

  1. Intervention Delivery. Participants assigned to the experimental Partner Notification intervention will be provided with standard partner notification counseling as well as 5 printed referral cards with information about syphilis infection and a referral sheet for the Spanish language version of the inSPOT internet-based partner notification service (www.inspot.org). Referral cards will include printed material informing the recipient that they may have been exposed to syphilis, and will provide information on syphilis infection, including local resources for testing and treatment. The inSPOT website is a free internet-based notification service that offers anonymous automated e-mail partner notification services following an STI diagnosis. Users of the system select a diagnosis as well as a standardized notification message which they can personalized with their name and other messages if they desire. The user then enters the e-mail address(es) of the person(s) they wish to notify and the system delivers an automated e-mail notification to the person advising them of their potential exposure to an STI and advising them to seek STI testing. The notification also includes the address of the inSPOT website which contains additional information on HIV/STIs, risks for transmission, and resources for testing and treatment. Participants will be instructed on how to use both tools to assist them in the partner notification process.

Participants randomized to the control arm will receive standard partner notification counseling by study staff, without any supplemental notification tools.

Following delivery of the intervention, an appointment will be scheduled for participants to return to the research site in 1 month.

VI. Follow-up Evaluation. All participants will be asked to return to the study site 1 month after enrollment and randomization. At the Follow-up evaluation, participants will complete a brief survey (Partner Notification Follow-up Survey).

VII. Survey: Participants will complete a brief follow-up survey assessing their general partner notification behavior as well as the actual notification and treatment outcome for each of their three most recent partners, as well as factors that impeded and/or promoted partner notification and treatment. Participants will be asked to specify whether each partner was notified, whether they received antibiotic treatment and/or sought STI testing, the participant's degree of certainty of the outcomes, and the reasons why each partner was or was not notified and/or treated.

VIII. Confirmation of Partner Notification: In order to provide independent confirmation of participant-reported notification status, study staff will ask participants for permission to conduct third party partner notification and confirmation of reported notification status. Participants will be asked for permission to contact their recent partner(s) by telephone or e-mail to confirm the notification outcome. Subjects will be informed that they are not obligated to provide contact information for any of their partners. Subjects will also be informed that if they provide contact information for their partner(s), study staff will contact the person using the contact information provided and notify the person only that someone they recently had sex with has been diagnosed with syphilis, provide information on local sites offering free or low cost testing for HIV and STIs, and answer any questions the partner might have. Subjects will be informed that study staff will not reveal the participant's name or other identifying information to their partner(s). If the participant provides contact information for their partner(s), study staff will contact the person and provide third-party partner notification using an IRB-approved script. After completing the partner notification process, study staff will ask the partner only if they had previously been notified by a partner about an STI diagnosis ("Yes/No"). Partners will not be asked for any additional information.

IX. Qualitative Evaluation. A randomly selected subgroup of participants in the Partner Notification Intervention Protocol will be invited to participate in individual interviews about the partner notification process. Each participant will be asked to participate in two interviews, one following randomization and one following the Follow-up Visit. Participants will complete a separate informed consent process for the individual interview and will receive additional compensation for their participation.

  1. Eligibility. A randomly selected subset of participants from the Partner Notification intervention protocol will be invited to participate in the individual qualitative interviews. Every fourth participant randomized will be invited to participate in an individual interview until reaching the projected qualitative study sample of 20 participants (10 each from the intervention and control arms). Participants will be asked to complete a separate informed consent document indicating their willingness to participate in a qualitative interview.

XI. Interview Conduct. Interviews will be conducted in Spanish in a private room by a trained interviewer. Interviews will be recorded and transcribed verbatim. Participants will be advised that they can stop the interview at any time and that they will be able to stop the tape and erase any response during the interview if they desire.

XII. Interview Content: Baseline interviews will focus on individual decision-making processes regarding partner notification in specific partnership contexts with a focus on the influence of: STI-related stigma and shame; the gender and sexual identity of participants and their partner(s); perceived power differentials within the partnership(s); patterns of communication within the partnership(s); and structural access to testing and treatment.

Follow-up interviews will discuss actual notification and treatment outcomes. Follow-up interviews will emphasize: barriers or catalysts to implementing notification decisions in specific partnership contexts; structural access to partner testing and treatment within local social, cultural, and economic contexts; and the effectiveness of the study's quantitative outcomes in accurately measuring participants' lived experiences.

Each interview is expected to last approximately 20-30 minutes. Audio recordings and transcripts of interviews will be identified by the participant's numeric study code and the date of the interview.

Being tested
Internet, Referral Card, Internet and Referral Card
Keywords
MSM, Transgender Women, Partner Notification, Syphilis, Peru
Medical subject headings
Syphilis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • InternetBehavioural

    Referral and user instructions for Peru section of www.inspot.org partner notification website

  • Referral CardBehavioural

    5 printed referral cards with information on syphilis signs, symptoms, diagnosis, treatment, and local resources.

  • Internet and Referral CardBehavioural

    5 printed referral cards with information on syphilis signs, symptoms, diagnosis, treatment, and local resources; Referral and user instructions for Peru section of www.inspot.org partner notification website.

Study groups in NCT01720641
Study groupRoleWhat they receive
ControlNo interventionStandardized partner notification counseling
Internet NotificationExperimentalStandardized partner notification counseling and referral to internet-based partner referral website.
Receives: Behavioral: Internet
Referral CardExperimentalStandardized partner notification counseling and provision of 5 printed partner referral cards.
Receives: Behavioral: Referral Card
Internet and Referral CardExperimentalStandardized partner notification counseling and referral to internet-based partner referral website and provision of 5 printed partner referral cards.
Receives: Behavioral: Internet and Referral Card

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-Reported Partner Notification

    Participant self-report of recent partner notification at 14-21 days of follow-up.

    Measured: 21 days

Secondary outcomes (1)
  1. Investigator-confirmed Partner Notification

    Participants who report notifying one or more of their three most recent partners will be asked for permission for the investigators to contact one or more of these partners to confirm notification outcomes. Partners who are successfully contacted and confirm prior partner notification will be defined as confirmed notifications.

    Measured: 21 Days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2012 (estimated)
  2. Study startAug 2012
  3. Primary completionAug 2014
  4. Study completionAug 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
370 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01720641
Sponsor's protocol ID
K23MH084611
Other IDs
IMP-478-2012, K23MH084611
Status last verified
Aug 2014
First submitted
29 Oct 2012
Last updated
6 Aug 2014
Results posted
No
Data monitoring committee
No

Publications

  • Clark JL, Segura ER, Oldenburg CE, Salvatierra HJ, Rios J, Perez-Brumer AG, Gonzales P, Sheoran B, Sanchez J, Lama JR. Traditional and Web-Based Technologies to Improve Partner Notification Following Syphilis Diagnosis Among Men Who Have Sex With Men in Lima, Peru: Pilot Randomized Controlled Trial. J Med Internet Res. 2018 Jul 3;20(7):e232. doi: 10.2196/jmir.9821.

    PubMed 29970355
  • Braun HM, Segura ER, Lake JE, Gandhi M, Rios J, Villaran MV, Sanchez J, Lama JR, Clark JL. Individual and partnership factors associated with anticipated versus actual partner notification following STI diagnosis among men who have sex with men and/or with transgender women in Lima, Peru. Sex Transm Infect. 2018 Dec;94(8):607-610. doi: 10.1136/sextrans-2017-053292. Epub 2017 Nov 30.

    PubMed 29191814

Questions about this trial

What is this clinical trial studying?

A study testing Internet, Referral Card and Internet and Referral Card in people with Partner Notification Following STI Diagnosis, run by University of California, Los Angeles at 1 site in Peru.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Peru. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-Reported Partner Notification (time frame: 21 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01720641, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in